22,135,656
Vote Records
28,570
Companies
12,092
Funds
3,981
Managers

Home › Companies › NIAGEN BIOSCIENCE INC. › 2024-2025

NIAGEN BIOSCIENCE INC. 2024-2025 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and NIAGEN BIOSCIENCE INC.’s Form 8-K, filed June 27, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 12Ballot items
  • 148Asset managers, any item
  • 1,576Fund votes
  • June 24, 2025Meeting date

Results at a glance

Meeting of June 24, 2025: 12 items on NIAGEN BIOSCIENCE INC.’s Form 8-K, filed June 27, 2025: 8 elected · 4 passed (calculated).

Dissent

Significant dissent: 1 director (22.1% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore NIAGEN BIOSCIENCE INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by NIAGEN BIOSCIENCE INC.

These tallies are NIAGEN BIOSCIENCE INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 27, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

NIAGEN BIOSCIENCE INC. — official shareholder meeting results, meeting held June 24, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Frank L. Jaksch Jr. 55,702,257---- 414,3059,590,210 99.3%Elected—
Elect Director: Robert Fried 55,727,380---- 389,1829,590,210 99.3%Elected—
Elect Director: Steven Rubin 43,688,502---- 12,428,0609,590,210 78%Elected—
Elect Director: Wendy Yu 55,228,815---- 887,7479,590,210 98%Elected—
Elect Director: Gary Ng 55,782,912---- 333,6509,590,210 99.4%Elected—
Elect Director: Kristin Patrick 54,799,493---- 1,317,0699,590,210 98%Elected—
Elect Director: Ann Cohen 55,714,463---- 402,0999,590,210 99.3%Elected—
Elect Director: Hamed Shahbazi 51,874,556---- 4,242,0069,590,210 92%Elected—
2. Ratification of the appointment of Crowe LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 63,361,6392,306,05639,077 ---- 96%Passed (calculated)—
3. Approval, on an advisory basis, of the compensation paid to the Company's named executive officers 54,899,4831,160,61956,460 --9,590,210 98%Passed (calculated)—
4. Approval of amendment to the Company's 2017 Equity Incentive Plan to increase the number of shares available for issuance by 4.75 million shares of common stock 53,046,2292,979,06391,270 --9,590,210 95%Passed (calculated)—
5. Approval of the Company's Employee Stock Purchase Plan 55,668,384366,75881,420 --9,590,210 99.3%Passed (calculated)—

Source: NIAGEN BIOSCIENCE INC., Form 8-K, filed with the SEC on June 27, 2025 — read the filing on EDGAR.

How asset managers voted at the NIAGEN BIOSCIENCE INC. 2024-2025 meeting

148 asset managers disclosed a vote on at least one NIAGEN BIOSCIENCE INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Ann Cohen

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%
FOR: 55,714,463WITHHELD: 402,099

Prior year: 98.3% for (June 20, 2024 meeting) ▲ 1.0 pts

Details: description as filed, official tally, votes by 47 asset managers

Description as filed by funds: Election of Directors: Ann Cohen

NIAGEN BIOSCIENCE INC.’s own tally for this item (“Elect Director: Ann Cohen”): 55,714,463 for, 402,099 withheld, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2026 Annual Meeting of Stockholders and until his or her successor is elected, or, if sooner, until such director's death, resignation or removal.”
Support: 99.3% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 47 asset managers below reported 8,211,793 for.

FOR
FOR: 8,211,793
Largest asset managers voting on “Election of Directors: Ann Cohen” at NIAGEN BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,823,9340 00For
BlackRock1,393,3410 00For
Fidelity1,228,6520 00For
TIAA205,4610 00For
Gabelli194,8000 00For
FORUM FUNDS II149,4260 00For
Charles Schwab148,7800 00For
SEI143,5120 00For
Equitable113,9970 00For
Goldman Sachs92,5890 00For
BRIDGEWAY FUNDS INC92,1790 00For
QUANTITATIVE MASTER SERIES LLC68,2840 00For
Lincoln Financial67,7630 00For
American Century48,4450 00For
Exchange Place Advisors Trust41,1400 00For
AQR41,0830 00For
Global X29,5990 00For
AIG/SunAmerica26,9200 00For
TETON WESTWOOD FUNDS25,0000 00For
Columbia Threadneedle23,1530 00For
Northern Trust22,7690 00For
WisdomTree21,2270 00For
PERRITT FUNDS INC20,0000 00For
John Hancock18,6060 00For
Brighthouse18,2510 00For

Showing the 25 largest of 47 asset managers. All 47 are in the interactive database (link above).

Elect Director: Frank L. Jaksch Jr.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%
FOR: 55,702,257WITHHELD: 414,305

Prior year: 98.0% for (June 20, 2024 meeting) ▲ 1.3 pts

Details: description as filed, official tally, votes by 47 asset managers

Description as filed by funds: Election of Directors: Frank Jaksch, Jr.

NIAGEN BIOSCIENCE INC.’s own tally for this item (“Elect Director: Frank L. Jaksch Jr.”): 55,702,257 for, 414,305 withheld, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2026 Annual Meeting of Stockholders and until his or her successor is elected, or, if sooner, until such director's death, resignation or removal.”
Support: 99.3% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 47 asset managers below reported 8,206,017 for, 5,776 withheld.

FOR
FOR: 8,206,017WITHHOLD: 5,776
Largest asset managers voting on “Election of Directors: Frank Jaksch, Jr.” at NIAGEN BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,823,9340 00For
BlackRock1,393,3410 00For
Fidelity1,228,6520 00For
TIAA205,4610 00For
Gabelli194,8000 00For
FORUM FUNDS II149,4260 00For
Charles Schwab148,7800 00For
SEI143,5120 00For
Equitable113,9970 00For
Goldman Sachs92,5890 00For
BRIDGEWAY FUNDS INC92,1790 00For
QUANTITATIVE MASTER SERIES LLC68,2840 00For
Lincoln Financial67,7630 00For
American Century48,4450 00For
Exchange Place Advisors Trust41,1400 00For
AQR41,0830 00For
Global X29,5990 00For
AIG/SunAmerica26,9200 00For
TETON WESTWOOD FUNDS25,0000 00For
Columbia Threadneedle23,1530 00For
Northern Trust22,7690 00For
WisdomTree21,2270 00For
PERRITT FUNDS INC20,0000 00For
John Hancock18,6060 00For
Brighthouse18,2510 00For

Showing the 25 largest of 47 asset managers. All 47 are in the interactive database (link above).

Elect Director: Gary Ng

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 55,782,912WITHHELD: 333,650

Prior year: 98.3% for (June 20, 2024 meeting) ▲ 1.1 pts

Details: description as filed, official tally, votes by 47 asset managers

Description as filed by funds: Election of Directors: Gary Ng

NIAGEN BIOSCIENCE INC.’s own tally for this item (“Elect Director: Gary Ng”): 55,782,912 for, 333,650 withheld, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2026 Annual Meeting of Stockholders and until his or her successor is elected, or, if sooner, until such director's death, resignation or removal.”
Support: 99.4% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 47 asset managers below reported 8,211,793 for.

FOR
FOR: 8,211,793
Largest asset managers voting on “Election of Directors: Gary Ng” at NIAGEN BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,823,9340 00For
BlackRock1,393,3410 00For
Fidelity1,228,6520 00For
TIAA205,4610 00For
Gabelli194,8000 00For
FORUM FUNDS II149,4260 00For
Charles Schwab148,7800 00For
SEI143,5120 00For
Equitable113,9970 00For
Goldman Sachs92,5890 00For
BRIDGEWAY FUNDS INC92,1790 00For
QUANTITATIVE MASTER SERIES LLC68,2840 00For
Lincoln Financial67,7630 00For
American Century48,4450 00For
Exchange Place Advisors Trust41,1400 00For
AQR41,0830 00For
Global X29,5990 00For
AIG/SunAmerica26,9200 00For
TETON WESTWOOD FUNDS25,0000 00For
Columbia Threadneedle23,1530 00For
Northern Trust22,7690 00For
WisdomTree21,2270 00For
PERRITT FUNDS INC20,0000 00For
John Hancock18,6060 00For
Brighthouse18,2510 00For

Showing the 25 largest of 47 asset managers. All 47 are in the interactive database (link above).

Elect Director: Hamed Shahbazi

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%
FOR: 51,874,556WITHHELD: 4,242,006

Prior year: 96.5% for (June 20, 2024 meeting) ▼ 4.1 pts

Details: description as filed, official tally, votes by 47 asset managers

Description as filed by funds: Election of Directors: Hamed Shahbazi

NIAGEN BIOSCIENCE INC.’s own tally for this item (“Elect Director: Hamed Shahbazi”): 51,874,556 for, 4,242,006 withheld, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2026 Annual Meeting of Stockholders and until his or her successor is elected, or, if sooner, until such director's death, resignation or removal.”
Support: 92% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 47 asset managers below reported 6,545,455 for, 1,666,338 withheld.

FORWITHHOLD
FOR: 6,545,455WITHHOLD: 1,666,338
Largest asset managers voting on “Election of Directors: Hamed Shahbazi” at NIAGEN BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,823,9340 00For
BlackRock00 01,393,341Withhold
Fidelity1,228,6520 00For
TIAA205,4610 00For
Gabelli194,8000 00For
FORUM FUNDS II149,4260 00For
Charles Schwab148,7800 00For
SEI143,5120 00For
Equitable00 0113,997Withhold
Goldman Sachs92,5890 00For
BRIDGEWAY FUNDS INC92,1790 00For
QUANTITATIVE MASTER SERIES LLC00 068,284Withhold
Lincoln Financial67,7630 00For
American Century48,4450 00For
Exchange Place Advisors Trust41,1400 00For
AQR41,0830 00For
Global X29,5990 00For
AIG/SunAmerica26,9200 00For
TETON WESTWOOD FUNDS25,0000 00For
Columbia Threadneedle23,1530 00For
Northern Trust00 022,769Withhold
WisdomTree21,2270 00For
PERRITT FUNDS INC20,0000 00For
John Hancock18,6060 00For
Brighthouse18,2510 00For

Showing the 25 largest of 47 asset managers. All 47 are in the interactive database (link above).

Elect Director: Kristin Patrick

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 54,799,493WITHHELD: 1,317,069

Prior year: 98.4% for (June 20, 2024 meeting) ▼ 0.8 pts

Details: description as filed, official tally, votes by 47 asset managers

Description as filed by funds: Election of Directors: Kristin Patrick

NIAGEN BIOSCIENCE INC.’s own tally for this item (“Elect Director: Kristin Patrick”): 54,799,493 for, 1,317,069 withheld, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2026 Annual Meeting of Stockholders and until his or her successor is elected, or, if sooner, until such director's death, resignation or removal.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 47 asset managers below reported 8,165,828 for, 45,965 withheld.

FOR
FOR: 8,165,828WITHHOLD: 45,965
Largest asset managers voting on “Election of Directors: Kristin Patrick” at NIAGEN BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,823,9340 00For
BlackRock1,393,3410 00For
Fidelity1,228,6520 00For
TIAA205,4610 00For
Gabelli194,8000 00For
FORUM FUNDS II149,4260 00For
Charles Schwab148,7800 00For
SEI143,5120 00For
Equitable113,9970 00For
Goldman Sachs92,5890 00For
BRIDGEWAY FUNDS INC92,1790 00For
QUANTITATIVE MASTER SERIES LLC68,2840 00For
Lincoln Financial31,4630 036,300Mixed
American Century48,4450 00For
Exchange Place Advisors Trust41,1400 00For
AQR41,0830 00For
Global X29,5990 00For
AIG/SunAmerica26,9200 00For
TETON WESTWOOD FUNDS25,0000 00For
Columbia Threadneedle23,1530 00For
Northern Trust22,7690 00For
WisdomTree21,2270 00For
PERRITT FUNDS INC20,0000 00For
John Hancock18,6060 00For
Brighthouse18,2510 00For

Showing the 25 largest of 47 asset managers. All 47 are in the interactive database (link above).

Elect Director: Robert Fried

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%
FOR: 55,727,380WITHHELD: 389,182

Prior year: 98.0% for (June 20, 2024 meeting) ▲ 1.3 pts

Details: description as filed, official tally, votes by 47 asset managers

Description as filed by funds: Election of Directors: Robert Fried

NIAGEN BIOSCIENCE INC.’s own tally for this item (“Elect Director: Robert Fried”): 55,727,380 for, 389,182 withheld, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2026 Annual Meeting of Stockholders and until his or her successor is elected, or, if sooner, until such director's death, resignation or removal.”
Support: 99.3% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 47 asset managers below reported 8,211,793 for.

FOR
FOR: 8,211,793
Largest asset managers voting on “Election of Directors: Robert Fried” at NIAGEN BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,823,9340 00For
BlackRock1,393,3410 00For
Fidelity1,228,6520 00For
TIAA205,4610 00For
Gabelli194,8000 00For
FORUM FUNDS II149,4260 00For
Charles Schwab148,7800 00For
SEI143,5120 00For
Equitable113,9970 00For
Goldman Sachs92,5890 00For
BRIDGEWAY FUNDS INC92,1790 00For
QUANTITATIVE MASTER SERIES LLC68,2840 00For
Lincoln Financial67,7630 00For
American Century48,4450 00For
Exchange Place Advisors Trust41,1400 00For
AQR41,0830 00For
Global X29,5990 00For
AIG/SunAmerica26,9200 00For
TETON WESTWOOD FUNDS25,0000 00For
Columbia Threadneedle23,1530 00For
Northern Trust22,7690 00For
WisdomTree21,2270 00For
PERRITT FUNDS INC20,0000 00For
John Hancock18,6060 00For
Brighthouse18,2510 00For

Showing the 25 largest of 47 asset managers. All 47 are in the interactive database (link above).

Elect Director: Steven Rubin

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

78% Majority: yes · of votes cast

FOR 78%WITHHELD
FOR: 43,688,502WITHHELD: 12,428,060

Prior year: 79.6% for (June 20, 2024 meeting) ▼ 1.8 pts

Details: description as filed, official tally, votes by 47 asset managers

Description as filed by funds: Election of Directors: Steven Rubin

NIAGEN BIOSCIENCE INC.’s own tally for this item (“Elect Director: Steven Rubin”): 43,688,502 for, 12,428,060 withheld, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2026 Annual Meeting of Stockholders and until his or her successor is elected, or, if sooner, until such director's death, resignation or removal.”
Support: 78% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 47 asset managers below reported 2,669,893 for, 5,541,900 withheld.

FORWITHHOLD
FOR: 2,669,893WITHHOLD: 5,541,900
Largest asset managers voting on “Election of Directors: Steven Rubin” at NIAGEN BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard316,2000 03,507,734Mixed
BlackRock00 01,393,341Withhold
Fidelity1,228,6520 00For
TIAA205,4610 00For
Gabelli194,8000 00For
FORUM FUNDS II149,4260 00For
Charles Schwab00 0148,780Withhold
SEI00 0143,512Withhold
Equitable00 0113,997Withhold
Goldman Sachs92,5890 00For
BRIDGEWAY FUNDS INC92,1790 00For
QUANTITATIVE MASTER SERIES LLC00 068,284Withhold
Lincoln Financial67,7630 00For
American Century48,4450 00For
Exchange Place Advisors Trust00 041,140Withhold
AQR41,0830 00For
Global X00 029,599Withhold
AIG/SunAmerica26,9200 00For
TETON WESTWOOD FUNDS25,0000 00For
Columbia Threadneedle23,1530 00For
Northern Trust00 022,769Withhold
WisdomTree21,2270 00For
PERRITT FUNDS INC20,0000 00For
John Hancock18,6060 00For
Brighthouse18,2510 00For

Showing the 25 largest of 47 asset managers. All 47 are in the interactive database (link above).

Elect Director: Wendy Yu

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 55,228,815WITHHELD: 887,747

Prior year: 99.2% for (June 20, 2024 meeting) ▼ 0.8 pts

Details: description as filed, official tally, votes by 47 asset managers

Description as filed by funds: Election of Directors: Wendy Yu

NIAGEN BIOSCIENCE INC.’s own tally for this item (“Elect Director: Wendy Yu”): 55,228,815 for, 887,747 withheld, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2026 Annual Meeting of Stockholders and until his or her successor is elected, or, if sooner, until such director's death, resignation or removal.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 47 asset managers below reported 8,211,793 for.

FOR
FOR: 8,211,793
Largest asset managers voting on “Election of Directors: Wendy Yu” at NIAGEN BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,823,9340 00For
BlackRock1,393,3410 00For
Fidelity1,228,6520 00For
TIAA205,4610 00For
Gabelli194,8000 00For
FORUM FUNDS II149,4260 00For
Charles Schwab148,7800 00For
SEI143,5120 00For
Equitable113,9970 00For
Goldman Sachs92,5890 00For
BRIDGEWAY FUNDS INC92,1790 00For
QUANTITATIVE MASTER SERIES LLC68,2840 00For
Lincoln Financial67,7630 00For
American Century48,4450 00For
Exchange Place Advisors Trust41,1400 00For
AQR41,0830 00For
Global X29,5990 00For
AIG/SunAmerica26,9200 00For
TETON WESTWOOD FUNDS25,0000 00For
Columbia Threadneedle23,1530 00For
Northern Trust22,7690 00For
WisdomTree21,2270 00For
PERRITT FUNDS INC20,0000 00For
John Hancock18,6060 00For
Brighthouse18,2510 00For

Showing the 25 largest of 47 asset managers. All 47 are in the interactive database (link above).

Approval of amendment to the Company's 2017 Equity Incentive Plan to increase the number of shares available for…

Calculated outcomeCOMPENSATIONPassed (calculated)

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 53,046,229AGAINST: 2,979,063
Details: description as filed, official tally, votes by 48 asset managers

Description as filed by funds: APPROVAL OF AMENDMENT TO THE COMPANY'S 2017 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE BY 4.75 MILLION SHARES OF COMMON STOCK

NIAGEN BIOSCIENCE INC.’s own tally for this item (“4. Approval of amendment to the Company's 2017 Equity Incentive Plan to increase the number of shares available for issuance by 4.75 million shares of common stock”): 53,046,229 for, 2,979,063 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a majority of the shares present or represented, the standard stated in the company’s proxy statement: votes for exceeded votes against plus abstentions.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 48 asset managers below reported 7,961,683 for, 314,210 against.

FOR
FOR: 7,961,683AGAINST: 314,210
Largest asset managers voting on “APPROVAL OF AMENDMENT TO THE COMPANY'S 2017 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES AVAILABLE F” at NIAGEN BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,823,9340 00For
BlackRock1,393,3410 00For
Fidelity1,228,6520 00For
TIAA205,4610 00For
Gabelli0194,800 00Against
FORUM FUNDS II149,4260 00For
Charles Schwab148,7800 00For
SEI143,5120 00For
Equitable113,9970 00For
Goldman Sachs92,5890 00For
BRIDGEWAY FUNDS INC92,1790 00For
QUANTITATIVE MASTER SERIES LLC68,2840 00For
Lincoln Financial31,46336,300 00Mixed
ALGERT GLOBAL LLC64,1000 00For
American Century048,445 00Against
Exchange Place Advisors Trust41,1400 00For
AQR41,0830 00For
Global X29,5990 00For
AIG/SunAmerica26,9200 00For
TETON WESTWOOD FUNDS025,000 00Against
Columbia Threadneedle23,1530 00For
Northern Trust22,7690 00For
WisdomTree21,2270 00For
PERRITT FUNDS INC20,0000 00For
John Hancock18,6060 00For

Showing the 25 largest of 48 asset managers. All 48 are in the interactive database (link above).

Approval of the Company's Employee Stock Purchase Plan

Calculated outcomeCOMPENSATIONPassed (calculated)

Combines 2 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%
FOR: 55,668,384AGAINST: 366,758
Details: description as filed, official tally, votes by 47 asset managers

Description as filed by funds: APPROVAL OF THE COMPANY'S EMPLOYEE STOCK PURCHASE PLAN

NIAGEN BIOSCIENCE INC.’s own tally for this item (“5. Approval of the Company's Employee Stock Purchase Plan”): 55,668,384 for, 366,758 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 47 asset managers below reported 8,211,793 for.

FOR
FOR: 8,211,793
Largest asset managers voting on “APPROVAL OF THE COMPANY'S EMPLOYEE STOCK PURCHASE PLAN” at NIAGEN BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,823,9340 00For
BlackRock1,393,3410 00For
Fidelity1,228,6520 00For
TIAA205,4610 00For
Gabelli194,8000 00For
FORUM FUNDS II149,4260 00For
Charles Schwab148,7800 00For
SEI143,5120 00For
Equitable113,9970 00For
Goldman Sachs92,5890 00For
BRIDGEWAY FUNDS INC92,1790 00For
QUANTITATIVE MASTER SERIES LLC68,2840 00For
Lincoln Financial67,7630 00For
American Century48,4450 00For
Exchange Place Advisors Trust41,1400 00For
AQR41,0830 00For
Global X29,5990 00For
AIG/SunAmerica26,9200 00For
TETON WESTWOOD FUNDS25,0000 00For
Columbia Threadneedle23,1530 00For
Northern Trust22,7690 00For
WisdomTree21,2270 00For
PERRITT FUNDS INC20,0000 00For
John Hancock18,6060 00For
Brighthouse18,2510 00For

Showing the 25 largest of 47 asset managers. All 47 are in the interactive database (link above).

Approval, on an advisory basis, of the compensation paid to the Company's named executive officers

Calculated outcomeFund totals may overlapSECTION 14A SAY-ON-PAY VOTESPassed (calculated)

Combines 7 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 54,899,483AGAINST: 1,160,619

Prior year: 97.9% for (June 20, 2024 meeting) ▲ 0.1 pts

Details: description as filed, official tally, votes by 148 asset managers

Description as filed by funds: APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE ACCOMPANYING PROXY STATEMENT

NIAGEN BIOSCIENCE INC.’s own tally for this item (“3. Approval, on an advisory basis, of the compensation paid to the Company's named executive officers”): 54,899,483 for, 1,160,619 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 47 asset managers voting on “APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE ACCOM” at NIAGEN BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,823,9340 00For
BlackRock1,393,3410 00For
Fidelity1,228,6520 00For
TIAA205,4610 00For
Gabelli194,8000 00For
FORUM FUNDS II149,4260 00For
Charles Schwab148,7800 00For
SEI143,5120 00For
Equitable113,9970 00For
Goldman Sachs92,5890 00For
BRIDGEWAY FUNDS INC092,179 00Against
QUANTITATIVE MASTER SERIES LLC68,2840 00For
Lincoln Financial67,7630 00For
American Century48,4450 00For
Exchange Place Advisors Trust41,1400 00For
AQR41,0830 00For
Global X29,5990 00For
AIG/SunAmerica26,9200 00For
TETON WESTWOOD FUNDS25,0000 00For
Columbia Threadneedle23,1530 00For
Northern Trust22,7690 00For
WisdomTree21,2270 00For
PERRITT FUNDS INC20,0000 00For
John Hancock18,6060 00For
Brighthouse18,2510 00For

Fund voting reports, all 47 managers: 8,108,557 for, 103,236 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 117 asset managers voting on “APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE ACCOM” at NIAGEN BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock1,548,23116,405 00For
Tieton Capital Management, LLC1,505,9950 00For
DE Shaw1,339,5900 00For
GEODE CAPITAL MANAGEMENT, LLC1,217,6850 00For
State Street847,690182 00For
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP635,385203,241 00Mixed
Maryland State Retirement & Pension System462,9050 00For
Invesco341,2880 00For
Northern Trust314,2300 00For
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM291,7820 00For
AMERIPRISE FINANCIAL INC273,6450 00For
Hillsdale Investment Management Inc.261,7720 00For
Victory Capital217,1730 00For
Renaissance209,5200 00For
Nuveen205,4610 00For
Lazard0204,693 00Against
STATE OF WISCONSIN INVESTMENT BOARD158,2840 00For
MELLON INVESTMENTS Corp156,9130 00For
Charles Schwab148,7810 00For
AQR145,2340 00For
SEI143,5120 00For
Connor, Clark & Lunn Investment Management Ltd.133,9470 00For
MARSHALL WACE, LLP132,5690 00For
Gabelli124,9500 00For
PNC BANK, NATIONAL ASSOCIATION112,0000 00For

Institutional-manager reports, all 117 managers: 12,128,909 for, 643,796 against. Showing the 25 largest; every one is in the interactive database (link above).

Ratification of the appointment of Crowe LLP as the Company's independent registered public accounting firm for the…

Calculated outcomeAUDIT-RELATEDPassed (calculated)

Combines 2 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 63,361,639AGAINST: 2,306,056

Prior year: 93.6% for (June 20, 2024 meeting) ▲ 2.9 pts

Details: description as filed, official tally, votes by 47 asset managers

Description as filed by funds: RATIFICATION OF THE SELECTION OF CROWE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025

NIAGEN BIOSCIENCE INC.’s own tally for this item (“2. Ratification of the appointment of Crowe LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 63,361,639 for, 2,306,056 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a majority of the shares present or represented, the standard stated in the company’s proxy statement: votes for exceeded votes against plus abstentions.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 47 asset managers below reported 8,088,353 for, 123,440 against.

FOR
FOR: 8,088,353AGAINST: 123,440
Largest asset managers voting on “RATIFICATION OF THE SELECTION OF CROWE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL” at NIAGEN BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,823,9340 00For
BlackRock1,393,3410 00For
Fidelity1,228,6520 00For
TIAA205,4610 00For
Gabelli194,8000 00For
FORUM FUNDS II25,986123,440 00Mixed
Charles Schwab148,7800 00For
SEI143,5120 00For
Equitable113,9970 00For
Goldman Sachs92,5890 00For
BRIDGEWAY FUNDS INC92,1790 00For
QUANTITATIVE MASTER SERIES LLC68,2840 00For
Lincoln Financial67,7630 00For
American Century48,4450 00For
Exchange Place Advisors Trust41,1400 00For
AQR41,0830 00For
Global X29,5990 00For
AIG/SunAmerica26,9200 00For
TETON WESTWOOD FUNDS25,0000 00For
Columbia Threadneedle23,1530 00For
Northern Trust22,7690 00For
WisdomTree21,2270 00For
PERRITT FUNDS INC20,0000 00For
John Hancock18,6060 00For
Brighthouse18,2510 00For

Showing the 25 largest of 47 asset managers. All 47 are in the interactive database (link above).

Largest NIAGEN BIOSCIENCE INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 78,769,662 shares outstanding at the time of that meeting.

Fund voting reports: top NIAGEN BIOSCIENCE INC. shareholders by shares voted on “APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS…”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 4.85%
2BlackRock 1.77%
3Fidelity 1.56%
4TIAA 0.26%
5Gabelli 0.25%
6FORUM FUNDS II 0.19%
7Charles Schwab 0.19%
8SEI 0.18%
9Equitable 0.14%
10Goldman Sachs 0.12%
Institutional-manager reports: top NIAGEN BIOSCIENCE INC. shareholders by shares voted on “APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS…”, 2024-2025
#Asset manager % of shares outstanding
1BlackRock 1.99%
2Tieton Capital Management, LLC 1.91%
3DE Shaw 1.70%
4GEODE CAPITAL MANAGEMENT, LLC 1.55%
5State Street 1.08%
6ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.06%
7Maryland State Retirement & Pension System 0.59%
8Invesco 0.43%
9Northern Trust 0.40%
10STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 0.37%

Reported NIAGEN BIOSCIENCE INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

NIAGEN BIOSCIENCE INC. holdings and ownership disclosed for the 2024-2025 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
Chau Hoi Shuen Solina Holly19,294,356 24.49%Proxy statement (DEF 14A), proxy filed April 29, 2025
Robert Fried4,250,788 5.40%Proxy statement (DEF 14A), proxy filed April 29, 2025
Société des Produits Nestlé S.A3,816,794 4.85%Proxy statement (DEF 14A), proxy filed April 29, 2025
BlackRock3,617,071 4.59%Form 13F, quarter ended March 31, 2025
Vanguard Group3,540,663 4.49%Form 13F, quarter ended March 31, 2025
Frank L. Jaksch, Jr.2,756,196 3.50%Proxy statement (DEF 14A), proxy filed April 29, 2025
D.E. Shaw1,283,790 1.63%Form 13F, quarter ended March 31, 2025
Geode Capital1,179,217 1.50%Form 13F, quarter ended March 31, 2025
State Street927,238 1.18%Form 13F, quarter ended March 31, 2025
Millennium Management600,900 0.76%Form 13F, quarter ended March 31, 2025

Percentages above are of 78,769,662 shares outstanding, as reported by NIAGEN BIOSCIENCE INC. on its Form 10-Q dated May 5, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At NIAGEN BIOSCIENCE INC.'s shareholder meeting held June 24, 2025, in the 2024-2025 proxy season, 148 asset managers reported votes on at least one of its 12 ballot items in their SEC Form N-PX filings, covering 1,576 separate fund positions. On the most widely held item on that ballot — APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS… — FOR was 98% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: NIAGEN BIOSCIENCE INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 27, 2025.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from NIAGEN BIOSCIENCE INC.’s 10-Q dated May 5, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

NIAGEN BIOSCIENCE INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Cite this page

Proxy Votes Now, “NIAGEN BIOSCIENCE (NAGE) 2025 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/niagen-bioscience-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.